Style | Citing Format |
---|---|
MLA | Abharian PH, et al.. "Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method." Advanced Biomedical Research, vol. 9, no. 1, 2020, pp. 30-. |
APA | Abharian PH, Dehghan P, Hassaniabharian P, Jabalameli Z (2020). Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method. Advanced Biomedical Research, 9(1), 30-. |
Chicago | Abharian PH, Dehghan P, Hassaniabharian P, Jabalameli Z. "Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method." Advanced Biomedical Research 9, no. 1 (2020): 30-. |
Harvard | Abharian PH et al. (2020) 'Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method', Advanced Biomedical Research, 9(1), pp. 30-. |
Vancouver | Abharian PH, Dehghan P, Hassaniabharian P, Jabalameli Z. Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method. Advanced Biomedical Research. 2020;9(1):30-. |
BibTex | @article{ author = {Abharian PH and Dehghan P and Hassaniabharian P and Jabalameli Z}, title = {Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method}, journal = {Advanced Biomedical Research}, volume = {9}, number = {1}, pages = {30-}, year = {2020} } |
RIS | TY - JOUR AU - Abharian PH AU - Dehghan P AU - Hassaniabharian P AU - Jabalameli Z TI - Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method JO - Advanced Biomedical Research VL - 9 IS - 1 SP - 30 EP - PY - 2020 ER - |